Development of fever following first administration of zoledronate as a prognostic factor in advanced non-small cell lung cancer patients with bone metastases

Nitrogen-containing bisphosphonates (N-BPs), which are usually used for the treatment of advanced cancer with bone metastasis, occasionally cause fever following the first administration. However, it is unclear as to how the development of fever following the first administration of N-BP is associat...

Descripción completa

Detalles Bibliográficos
Autores principales: Izumi, Hiroki, Igishi, Tadashi, Yamasaki, Akira, Takeda, Kennichi, Yanai, Masaaki, Tanaka, Natsumi, Sakamoto, Tomohiro, Nishii-Ito, Shizuka, Touge, Hirokazu, Kodani, Masahiro, Matsumoto, Shingo, Kawasaki, Yuji, Shimizu, Eiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740853/
https://www.ncbi.nlm.nih.gov/pubmed/29285363
http://dx.doi.org/10.3892/mco.2017.1447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740853/
https://www.ncbi.nlm.nih.gov/pubmed/29285363
http://dx.doi.org/10.3892/mco.2017.1447

Ejemplares similares